Avoid the antitrust trap in Asia

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Avoid the antitrust trap in Asia

Are Chinese regulators unfairly targeting overseas companies for antitrust violations, in a bid to defend domestic industries?

nov2014cover-400.jpg

Don't get caught out in Asia

That’s certainly what the American Chamber of Commerce in China suggested, in a report published last month. It said members were concerned about “selective and subjective enforcement” and that companies were being forced to license patents at low royalty rates.

The concerns follow high-profile investigations into Qualcomm and InterDigital, as well as opposition in China and Korea to the Microsoft-Nokia merger.

In the cover story in Managing IP’s November issue, now available online, our Asia editor Peter Leung examines antitrust issues in Australia, India and China, and asks whether there is any truth to these perceptions and whether foreign companies are in fact soft targets.

It’s a complex story, and Peter provides a guide to the overlapping jurisdiction of China’s three government agencies with responsibility for competition law (Mofcom, the SAIC and the NDRC) as well as recent developments in Australia (the Harper Review) and India (where antitrust enforcement has been focused on copyright licensing and the automobile industry).

Peter blogged earlier this year about FRAND issues in China, but his latest analysis confirms that antitrust investigations can affect all IP owners, whatever rights they own and whatever industry they are in. The likelihood is that scrutiny in Asia will only increase as local economies grow and IP becomes more prominent. International rights owners need to be prepared.

Subscribers can read “Asian governments focus on IP and competition issues” now. Non-subscribers can access it with a free trial. Contact Bobby Dohil with any access enquiries.

more from across site and SHARED ros bottom lb

More from across our site

Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Practitioners have welcomed extended funding of the specialist police unit until 2029, while the UKIPO says it is exploring increased scale
Abion says integration with Baylos marks an important step in the company’s international expansion plans
Via Licensing Alliance continues its China push as another smartphone manufacturer joins patent pool as licensee
Law firm mergers have the potential to reshape IP teams, and partners who were at the coalface of previous tie-ups say early coordination and flexibility can make the difference
Women are entering the IP profession, but still too few are being trusted with the clients, cases, and credit that may open the path to leadership
In other news, Australia’s IP office has announced expanded search options, and an EPO report shed light on slow progress relating to women inventors in Europe
Managing IP speaks with up-and-coming women lawyers at five law firms about fighting imposter syndrome, maintaining work-life balance and why real representation matters
Gift this article